Venugopal Chenna

961 total citations
14 papers, 804 citations indexed

About

Venugopal Chenna is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Venugopal Chenna has authored 14 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Molecular Medicine. Recurrent topics in Venugopal Chenna's work include Curcumin's Biomedical Applications (4 papers), Cancer-related Molecular Pathways (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Venugopal Chenna is often cited by papers focused on Curcumin's Biomedical Applications (4 papers), Cancer-related Molecular Pathways (4 papers) and Hedgehog Signaling Pathway Studies (3 papers). Venugopal Chenna collaborates with scholars based in United States, Germany and Netherlands. Venugopal Chenna's co-authors include Anirban Maitra, Nathaniel R. Campbell, Charles Steenbergen, Samarjit Das, Dipankar Pramanik, Collins Karikari, Djahida Bedja, Brittany Dunkerly‐Eyring, Savita Bisht and Michelle A. Rudek and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Venugopal Chenna

14 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Venugopal Chenna United States 11 554 171 157 143 135 14 804
Dipankar Pramanik United States 9 484 0.9× 171 1.0× 225 1.4× 157 1.1× 141 1.0× 11 735
Longzhu Piao United States 18 473 0.9× 132 0.8× 152 1.0× 194 1.4× 40 0.3× 25 863
Santosh S. Dhule United States 6 470 0.8× 60 0.4× 241 1.5× 161 1.1× 165 1.2× 7 735
Mohsen Alipour Iran 16 392 0.7× 77 0.5× 77 0.5× 183 1.3× 46 0.3× 30 759
Xinlong Zang China 17 372 0.7× 128 0.7× 124 0.8× 211 1.5× 50 0.4× 25 854
Canfeza Sezgin Türkiye 14 325 0.6× 210 1.2× 108 0.7× 43 0.3× 41 0.3× 45 695
Yifang Zou China 13 321 0.6× 145 0.8× 111 0.7× 251 1.8× 40 0.3× 17 926
Subhash C. Chauhan United States 11 266 0.5× 98 0.6× 78 0.5× 69 0.5× 68 0.5× 31 499
Zhibo Hou China 16 591 1.1× 78 0.5× 415 2.6× 63 0.4× 43 0.3× 28 864
Shijun Zhu United States 15 365 0.7× 134 0.8× 61 0.4× 51 0.4× 158 1.2× 21 637

Countries citing papers authored by Venugopal Chenna

Since Specialization
Citations

This map shows the geographic impact of Venugopal Chenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Venugopal Chenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Venugopal Chenna more than expected).

Fields of papers citing papers by Venugopal Chenna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Venugopal Chenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Venugopal Chenna. The network helps show where Venugopal Chenna may publish in the future.

Co-authorship network of co-authors of Venugopal Chenna

This figure shows the co-authorship network connecting the top 25 collaborators of Venugopal Chenna. A scholar is included among the top collaborators of Venugopal Chenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Venugopal Chenna. Venugopal Chenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hu, Chaoxin, Venugopal Chenna, Shinichi Yabuuchi, et al.. (2015). Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models. Molecular Cancer Therapeutics. 14(7). 1532–1539. 60 indexed citations
2.
Das, Samarjit, Djahida Bedja, Nathaniel R. Campbell, et al.. (2014). miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo. PLoS ONE. 9(5). e96820–e96820. 158 indexed citations
3.
Chenna, Venugopal, Chaoxin Hu, & Saeed R. Khan. (2014). Synthesis and cytotoxicity studies of Hedgehog enzyme inhibitors SANT-1 and GANT-61 as anticancer agents. Journal of Environmental Science and Health Part A. 49(6). 641–647. 11 indexed citations
4.
Chen, Xinpu, Venugopal Chenna, Anirban Maitra, & Sridevi Devaraj. (2014). Nanocurcumin attenuates inflammation by decreasing Toll‐like receptor 2 and 4 expression and activity and promoting an anti‐inflammatory macrophage phenotype (830.22). The FASEB Journal. 28(S1). 2 indexed citations
5.
Pokkali, Supriya, Alvaro A. Ordoñez, Venugopal Chenna, Anirban Maitra, & Sanjay K. Jain. (2014). NanoCurcumin inhibits TNF-α in Mycobacterium tuberculosis-infected macrophages (MPF3P.821). The Journal of Immunology. 192(Supplement_1). 132.21–132.21. 1 indexed citations
6.
Hu, Chaoxin, Venugopal Chenna, Rajat Bannerji, et al.. (2013). Abstract B263: Combined inhibition of cyclin-dependent kinases (Dinaciclib) and AKT (MK-2206) or ERK (SCH772984) dramatically blocks pancreatic tumor growth and metastases in patient-derived orthotopic xenograft models.. Molecular Cancer Therapeutics. 12(11_Supplement). B263–B263. 1 indexed citations
8.
Pramanik, Dipankar, Nathaniel R. Campbell, Samarjit Das, et al.. (2012). A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget. 3(6). 640–650. 75 indexed citations
9.
Xu, Yang, Venugopal Chenna, Chaoxin Hu, et al.. (2011). Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma. Clinical Cancer Research. 18(5). 1291–1302. 60 indexed citations
10.
Chenna, Venugopal, Chaoxin Hu, Dipankar Pramanik, et al.. (2011). A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists. Molecular Cancer Therapeutics. 11(1). 165–173. 69 indexed citations
11.
Bisht, Savita, Masamichi Mizuma, Georg Feldmann, et al.. (2010). Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer. Molecular Cancer Therapeutics. 9(8). 2255–2264. 169 indexed citations
12.
Yadav, J. S., et al.. (2009). Formal total synthesis of borrelidin: synthesis of C1–C11 fragment via desymmetrization strategy. Tetrahedron Letters. 50(27). 3772–3775. 13 indexed citations
13.
Sahu, Bichismita, Venugopal Chenna, Kira L. Lathrop, et al.. (2009). Synthesis of Conformationally Preorganized and Cell-Permeable Guanidine-Based γ-Peptide Nucleic Acids (γGPNAs). The Journal of Organic Chemistry. 74(4). 1509–1516. 88 indexed citations
14.
Chenna, Venugopal, Srinivas Rapireddy, Bichismita Sahu, et al.. (2008). A Simple Cytosine to G‐Clamp Nucleobase Substitution Enables Chiral γ‐PNAs to Invade Mixed‐Sequence Double‐Helical B‐form DNA. ChemBioChem. 9(15). 2388–2391. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026